AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amryt Pharma Plc (NASDAQ: AMYT) to Chiesi Farmaceutici S.p.A. is fair to Amryt shareholders.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, January 9, 2023
Information
Tags: 
Class Action Lawsuit, Other Professional Services, Legal, Professional Services, Sale, ADS, Fraud, Contingent value rights, Advertising, Security (finance), Chiesi Farmaceutici
Geotags: 
ILLINOIS, NEW YORK, UNITED STATES, NORTH AMERICA
⚠ partially generated by AI ↴
Organisation: 
HALPER SADEH, HALPER SADEH LLC, AMRYT PHARMA
Stock Symbol: 
NASDAQ:AMYT
Summary
Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amryt Pharma Plc (NASDAQ: AMYT) to Chiesi Farmaceutici S.p.A. is fair to Amryt shareholders.
  • On behalf of Amryt shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
  • Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.


Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amryt Pharma Plc (NASDAQ: AMYT) to Chiesi Farmaceutici S.p.A. is fair to Amryt shareholders. Per the terms of the proposed transaction, Chiesi would acquire Amryt for $14.50 in cash per American Depositary Share (ADS) of Amryt plus Contingent Value Rights of up to $2.50 per ADS payable if certain milestones related to Amryt’s product Filsuvez® are achieved.

Halper Sadeh encourages Amryt shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

The investigation concerns whether Amryt and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Amryt shareholders; (2) determine whether Chiesi is underpaying for Amryt; and (3) disclose all material information necessary for Amryt shareholders to adequately assess and value the merger consideration. On behalf of Amryt shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Amryt shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Copyright: 
Copyright Business Wire 2023